Positive-allosteric modulation of the 5-HT2C receptor: implications for neuropsychopharmacology and neurotherapeutics

被引:0
|
作者
Jia Zhou
Kathryn A. Cunningham
机构
[1] University of Texas Medical Branch,Center for Addiction Research and Department of Pharmacology and Toxicology
来源
Neuropsychopharmacology | 2019年 / 44卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:230 / 231
页数:1
相关论文
共 50 条
  • [21] Characterizing the effects of 5-HT2C receptor ligands on motor activity and feeding behaviour in 5-HT2C receptor knockout mice
    Fletcher, Paul J.
    Tampakeras, Maria
    Sinyard, Judy
    Slassi, Abdelmalik
    Isaac, Methvin
    Higgins, Guy A.
    NEUROPHARMACOLOGY, 2009, 57 (03) : 259 - 267
  • [22] Modulation of 5-HT2A receptor-mediated head-twitch behaviour in the rat by 5-HT2C receptor agonists
    Vickers, SP
    Easton, N
    Malcolm, CS
    Allen, NH
    Porter, RH
    Bickerdike, MJ
    Kennett, GA
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2001, 69 (3-4) : 643 - 652
  • [23] Pleiotropic behavior of 5-HT2A and 5-HT2C receptor agonists
    Berg, KA
    Maayani, S
    Goldfarb, J
    Clarke, WP
    ADVANCES IN SEROTONIN RECEPTOR RESEARCH: MOLECULAR BIOLOGY, SIGNAL TRANSDUCTION, AND THERAPEUTICS, 1998, 861 : 104 - 110
  • [24] Modulation of 5-HT2A and 5-HT2C receptor expression levels by fluoxetine in a genetic mice model of depression
    Bjork, K.
    Zhang, X.
    El Yacoubi, M.
    Vaugeois, J.
    Svenningsson, P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S375 - S376
  • [25] Biophysical identification of the 5-HT2A receptor: 5-HT2C receptor interaction in vitro
    Felsing, Daniel Eric
    Anastasio, Noelle C.
    Miszkiel, Joanna M.
    Gilbertson, Scott
    Moeller, Frederick Gerrard
    Allen, John A.
    Cunningham, Kathryn A.
    FASEB JOURNAL, 2018, 32 (01):
  • [26] Indolines as 5-HT2C receptor ligands.
    Pratt, RM
    Adams, DR
    Bebbington, D
    Bentley, JM
    Benwell, K
    Bickerdike, MJ
    Cliffe, IA
    Davidson, JEP
    Dawson, CE
    Duncton, MAJ
    Gaur, S
    George, AR
    Giles, PR
    Hamlyn, RJ
    Kennett, GA
    Knight, T
    Malcolm, C
    Mansell, HL
    Misra, A
    Monck, NJT
    Roffey, JR
    Vickers, S
    Dourish, CT
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U67 - U67
  • [27] Comparative modulation of hippocampal 5-HT release by the 5-HT2C receptor antagonist SB 206553 and paroxetine
    Thorn, L
    Routledge, C
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 : P257 - P257
  • [28] Activating mutations of the serotonin 5-HT2C receptor
    HerrickDavis, K
    Egan, C
    Teitler, M
    JOURNAL OF NEUROCHEMISTRY, 1997, 69 (03) : 1138 - 1144
  • [29] Allelic variation in the 5-HT2C receptor (HTR2C) and functional responses to the 5-HT2C receptor agonist, m-chlorophenylpiperazine
    D. J. Quested
    R. Whale
    A. L. Sharpley
    C. L. McGavin
    N. Crossland
    P. J. Harrison
    P. J. Cowen
    Psychopharmacology, 1999, 144 : 306 - 307
  • [30] Roles of the 5-HT2C receptor on zebrafish sociality
    Moura, Layana Aquino de
    Pyterson, Maryana Pereira
    Pimentel, Ana Flavia Nogueira
    Araujo, Fernanda
    Souza, Loanne Valeria Xavier Bruce de
    Mendes, Caio Henrique Moura
    Costa, Bruna Patricia Dutra
    Siqueira-Silva, Diogenes Henrique de
    Maximino, Monica Lima-
    Maximino, Caio
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2023, 125